NEUROFIBROMATOSIS 1 (NF1)
Clinical trials for NEUROFIBROMATOSIS 1 (NF1) explained in plain language.
Never miss a new study
Get alerted when new NEUROFIBROMATOSIS 1 (NF1) trials appear
Sign up with your email to follow new studies for NEUROFIBROMATOSIS 1 (NF1), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for NF1 patients: drug may shrink inoperable tumors
Disease control OngoingThis study tests whether the drug selumetinib can shrink or slow the growth of nerve tumors called plexiform neurofibromas in adults with neurofibromatosis type 1 (NF1). Participants take the drug as capsules twice daily for 28-day cycles. The goal is to see if the tumors shrink …
Matched conditions: NEUROFIBROMATOSIS 1 (NF1)
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 06:50 UTC
-
Laser zaps NF1 skin bumps in new trial
Symptom relief TerminatedThis study tests whether monthly laser treatments can safely shrink skin tumors in people with NF1. Ten adults will receive up to six treatments, and researchers will check for side effects and tumor reduction. The goal is to improve the look and feel of these bumps without major…
Matched conditions: NEUROFIBROMATOSIS 1 (NF1)
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 22, 2026 14:04 UTC